MiRus announced new early feasibility study results supporting the use of its Siegel transcatheter aortic valve replacement ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers are exploring the use of a new drug called ataciguat to ...

Primary Source New England Journal of Medicine Source Reference: Hahn RT, et al "Transcatheter valve replacement in severe tricuspid regurgitation" N Engl J Med 2024; DOI: 10.1056/NEJMoa2401918.

Thubrikar Aortic Valve, Inc. is a privately held medical device company on a mission to revolutionize the treatment of Aortic Stenosis by bringing to the hands of physicians, and their patients, a ...

COLLEGEVILLE, Pa., October 01, 2024--Thubrikar Aortic Valve, Inc. today announced successful results in an additional 5 patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV ...

Kodali declared various ties to Anteris, TRiCares, Micro Interventional Devices, X-Dot, Supira, Adona, Tioga, Helix Valve Repair, Moray Medical, Nyra, Dura Biotech, Thubrikar Aortic Valve Inc ...

Shobini Jayaraman, Navneet Narula, Jagat Narula, Olga Gursky. Amyloid and collagen templates in aortic valve calcification. Trends in Molecular Medicine, 2024; DOI: 10.1016/j.molmed.2024.04.015 ...

There are three types of bicuspid aortic valves — types 0, 1, and 2. Experts classify these types based on whether the leaflets of the valve have fused to form a ridge. A bicuspid aortic valve ...

Thubrikar Aortic Valve said it received authorisation from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of its Optimum Transcatheter Aortic Valve Implantation System, allowing ...